
TY  - JOUR
TI  - Abstracts—Posters
JO  - Alcoholism: Clinical and Experimental Research
JA  - Alcohol Clin Exp Re
VL  - 43
IS  - S1
SN  - 0145-6008
UR  - https://doi.org/10.1111/acer.14059
DO  - doi:10.1111/acer.14059
SP  - 27A
EP  - 258A
PY  - 2019
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 20th Annual ACVIM Forum Dallas, TX, May 29-June 1, 2002
JO  - Journal of Veterinary Internal Medicine
VL  - 16
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.2002.tb02376.x
DO  - doi:10.1111/j.1939-1676.2002.tb02376.x
SP  - 318
EP  - 389
PY  - 2002
ER  - 

C7  - pp. 210-364
TI  - The Golden Age: Social Housing in an Era of Reconstruction and Growth
SN  - 9780631181828
UR  - https://doi.org/10.1002/9780470712825.ch4
DO  - doi:10.1002/9780470712825.ch4
SP  - 210-364
KW  - social housing
KW  - reconstruction
KW  - mass unemployment
KW  - social unrest
KW  - domestic markets
PY  - 2002
AB  - Summary This chapter contains section titled: The Aftermath of War Economic Reconstruction and Modernization The Politics of Economic Growth Social Housing in Europe?an Overview The Rise and Fall of Social Housing Notes
ER  - 

TY  - JOUR
TI  - Thursday, 28 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 9780631181828
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_4.x
DO  - doi:10.1111/j.1538-7836.2011.04380_4.x
SP  - 712
EP  - 959
PY  - 2011
ER  - 

AU  - Hossain, Nazli
AU  - Paidas, Michael J.
C7  - pp. 479-486
TI  - Disseminated Intravascular Coagulation
UR  - https://doi.org/10.1002/9781119129400.ch31
DO  - doi:10.1002/9781119129400.ch31
SP  - 479-486
KW  - acute fatty liver of pregnancy
KW  - amniotic fluid embolism
KW  - disseminated intravascular coagulation
KW  - HELLP syndrome
KW  - preeclampsia
KW  - pregnancy
PY  - 2011
AB  - Summary Disseminated intravascular coagulation (DIC) in pregnancy is most often encountered secondary to underlying obstetrical, surgical, or medical complications. The process of DIC is initiated through the activation of tissue factor (TF), which is found in subendothelial cells, amniotic fluid, and placenta. DIC is seen in severe forms of preeclampsia with hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome. Amniotic fluid embolism (AFE) is a catastrophic complication in obstetrics and is associated with significant maternal mortality. Acute fatty liver of pregnancy (AFLP) is a rare disease associated with massive obstetric hemorrhage. It is characterized by accumulation of microvesicular fatty infiltration in the maternal hepatocytes, leading to liver failure. The diagnosis of DIC is clinical, based upon underlying etiology, blood loss, and the general condition of the patient. The basic principles of managing obstetrical DIC are multidisciplinary approach, treatment of obstetric causes, blood and blood products, and supportive care.
ER  - 

TY  - JOUR
AU  - Hetzer, Roland
AU  - Potapov, E. V.
AU  - Huebler, S.
TI  - Proceedings of the 4th Berlin Symposium on Mechanical Circulatory Support, Berlin, Germany, December 9–10, 2005
JO  - Journal of Cardiac Surgery
VL  - 21
IS  - 5
UR  - https://doi.org/10.1111/j.1540-8191.2006.00288.x
DO  - doi:10.1111/j.1540-8191.2006.00288.x
SP  - 512
EP  - 520
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Haemophilia
JA  - Haemophilia
VL  - 22
IS  - S4
UR  - https://doi.org/10.1111/hae.12980
DO  - doi:10.1111/hae.12980
SP  - 3
EP  - 138
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Presentation Abstracts
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 19
IS  - S2
UR  - https://doi.org/10.1111/1756-185X.12962
DO  - doi:10.1111/1756-185X.12962
SP  - 21
EP  - 293
PY  - 2016
ER  - 

TY  - JOUR
TI  - EAO 19th Annual Scientific Meeting Abstracts
JO  - Clinical Oral Implants Research
VL  - 21
IS  - 10
UR  - https://doi.org/10.1111/j.1600-0501.2010.01994.x
DO  - doi:10.1111/j.1600-0501.2010.01994.x
SP  - 989
EP  - 1193
PY  - 2010
ER  - 

AU  - Seitz, Rainer
AU  - König, Herbert
AU  - Dodt, Johannes
C7  - pp. 1-39
TI  - Blood
SN  - 9783527303854
UR  - https://doi.org/10.1002/14356007.a04_201.pub2
DO  - doi:10.1002/14356007.a04_201.pub2
SP  - 1-39
PY  - 2010
AB  - Abstract The article contains sections titled: 1. Introduction 2. Composition, Physiology and Chemical Properties of Blood 2.1. Blood Cells 2.1.1. Hematopoiesis, Stem Cells 2.1.2. Red Cells, Hemoglobin 2.1.3. Leukocytes, Cytokins 2.1.4. Thrombocytes 2.2. Plasma Proteins 2.2.1. Analysis of Plasma 2.2.2. Coagulation Factors 2.2.3. Fibrinolysis System 2.2.4. Plasma Proteinase Inhibitors 2.2.5. Immunoglobulins 2.2.6. Albumin 3. Production 3.1. Blood and Plasma Donation 3.2. Substances Derived from Blood Cells 3.3. Fractionation of Plasma 3.3.1. Quality Requirements 3.3.2. Preparation of Intermediate Products 3.3.3. Purification of Plasma Proteins 3.4. Recombinant Proteins 3.5. Adverse Drug Reactions of Blood Products 3.5.1. Immunogenicity 3.5.2. Thrombogenicity 3.5.3. Transmittable Pathogens 4. Therapeutic Uses 4.1. Blood Components 4.1.1. Blood and Stem Cell Preparations 4.1.2. Fresh Frozen Plasma 4.2. Hemoglobin-Derived Oxygen Carriers 4.3. Cytokins 4.4. Coagulation Factors 4.5. Plasminogen Activators 4.6. Inhibitors 4.7. Immunoglobulins 4.8. Albumin 5. Economic Aspects Blood is a multifunctional transport medium of vital importance for the body of higher organisms. Its composition is very complex and includes various cell systems with peculiar functions, proteins, electrolytes, metabolites, and highly sophisticated mediator systems. Both cells and plasma, which can be separated by centrifugation, can be used as and further processed into medicines. Serum is the fluid remaining after coagulation of the blood. In this review, blood cell systems and plasma proteins are referred to and medicinal aspects including blood and plasma collection and processing are described. The medicines derived from blood and plasma, as well as basic research and clinical trials should keep an important place because of the medicine as a whole benefits extremely from transfusions and, in particular, hemophiliacs gain an enormous improvement of life quality and life expectancy.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Thrombosis and Haemostasis
VL  - 3
IS  - s1
SN  - 9783527303854
UR  - https://doi.org/10.1111/j.1538-7836.2005.0300b.x
DO  - doi:10.1111/j.1538-7836.2005.0300b.x
SP  - OR001
EP  - OR396
PY  - 2005
ER  - 

TY  - JOUR
AU  - Simak, Jan
AU  - De Paoli, Silvia
C7  - e1448
TI  - The effects of nanomaterials on blood coagulation in hemostasis and thrombosis
JO  - WIREs Nanomedicine and Nanobiotechnology
JA  - WIREs Nanomed Nanobiotechnol
VL  - 9
IS  - 5
SN  - 9783527303854
UR  - https://doi.org/10.1002/wnan.1448
DO  - doi:10.1002/wnan.1448
SP  - e1448
PY  - 2017
AB  - The blood coagulation balance in the organism is achieved by the interaction of the blood platelets (PLTs) with the plasma coagulation system (PCS) and the vascular endothelial cells. In healthy organism, these systems prevent thrombosis and, in events of vascular damage, enable blood clotting to stop bleeding. The dysregulation of hemostasis may cause serious thrombotic and/or hemorrhagic pathologies. Numerous engineered nanomaterials are being investigated for biomedical purposes and are unavoidably exposed to the blood. Also, nanomaterials may access vascular system after occupational, environmental, or other types of exposure. Thus, it is essential to evaluate the effects of engineered nanomaterials on hemostasis. This review focuses on investigations of nanomaterial interactions with the blood components involved in blood coagulation: the PCS and PLTs. Particular emphases include the pathophysiology of effects of nanomaterials on the PCS, including the kallikrein-kinin system, and on PLTs. Methods for investigating these interactions are briefly described, and a review of the most important studies on the interactions of nanomaterials with plasma coagulation and platelets is provided. WIREs Nanomed Nanobiotechnol 2017, 9:e1448. doi: 10.1002/wnan.1448 This article is categorized under: Implantable Materials and Surgical Technologies > Nanomaterials and Implants Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Muscle & Nerve
JA  - Muscle Nerve
VL  - 46
IS  - 4
SN  - 9783527303854
UR  - https://doi.org/10.1002/mus.23652
DO  - doi:10.1002/mus.23652
SP  - 621
EP  - 679
PY  - 2012
ER  - 

TY  - JOUR
TI  - ISLH 2017 Abstract Proceedings
JO  - International Journal of Laboratory Hematology
JA  - Int. Jnl. Lab. Hem.
VL  - 39
IS  - S2
SN  - 9783527303854
UR  - https://doi.org/10.1111/ijlh.12698
DO  - doi:10.1111/ijlh.12698
SP  - 3
EP  - 133
PY  - 2017
ER  - 

TY  - JOUR
TI  - Tentative Schedule of Abstract Presentations, April 28 to May 1, 2007, Tampa Convention Center
JO  - Wound Repair and Regeneration
VL  - 15
IS  - 2
SN  - 9783527303854
UR  - https://doi.org/10.1111/j.1524-475X.2007.00217.x
DO  - doi:10.1111/j.1524-475X.2007.00217.x
SP  - A13
EP  - A54
PY  - 2007
ER  - 

TY  - JOUR
TI  - POSTER SESSION 2, MONDAY 25 AUGUST
JO  - European Journal of Neurology
VL  - 15
IS  - s3
SN  - 9783527303854
UR  - https://doi.org/10.1111/j.1468-1331.2008.02286.x
DO  - doi:10.1111/j.1468-1331.2008.02286.x
SP  - 222
EP  - 390
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts-part III (Continue in Part IV)
JO  - Proceedings of the International Society for Magnetic Resonance in Medicine
JA  - Proc. Soc. Magn. Reson. Med.
VL  - 1989
IS  - S1
SN  - 9783527303854
UR  - https://doi.org/10.1002/mrmp.22419890105
DO  - doi:10.1002/mrmp.22419890105
SP  - 151
EP  - 201
PY  - 1989
ER  - 

TY  - JOUR
TI  - Presented at the thirteenth annual meeting of the American Association of Clinical Anatomists, June 12–June 14, 1996, Creighton University School of Medicine, Omaha, Nebraska
JO  - Clinical Anatomy
JA  - Clin. Anat.
VL  - 10
IS  - 2
SN  - 9783527303854
UR  - https://doi.org/10.1002/(SICI)1098-2353(1997)10:2<130::AID-CA11>3.0.CO;2-L
DO  - doi:10.1002/(SICI)1098-2353(1997)10:2<130::AID-CA11>3.0.CO;2-L
SP  - 130
EP  - 138
PY  - 1997
ER  - 

TY  - JOUR
TI  - 2003 Meeting of the Peripheral Nerve Society
JO  - Journal of the Peripheral Nervous System
VL  - 8
IS  - s1
SN  - 9783527303854
UR  - https://doi.org/10.1046/j.1529-8027.8.s1.1.x
DO  - doi:10.1046/j.1529-8027.8.s1.1.x
SP  - 1
EP  - 78
PY  - 2003
ER  - 

TY  - JOUR
TI  - Pathological Society of Great Britain and Ireland 168th Meeting, 5–7 January 1994. Hosted by Medical Colleges of the Royal London and St. Bartholomew's Hospital at the Queen Elizabeth II conference center London
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 172
IS  - S1
SN  - 9783527303854
UR  - https://doi.org/10.1002/path.1711720502
DO  - doi:10.1002/path.1711720502
SP  - A95
EP  - A165
PY  - 1994
ER  - 
